June 1, 2019 — Fast and easy is not an option for obesity care, unfortunately. Smart and reasonably effective options exist, but this is a chronic disease. Nobody can snap their fingers and make it go away. That’s probably why Vivus recently found itself in trouble with FDA for claiming three times faster weight loss with Qsymia. FDA Warning […]
November 3, 2015 — It’s a little hard to tell if we’re making progress toward better obesity care. Maybe that’s why it’s important to start a conversation about obesity care with National Obesity Care Week. It’s not like we’re lacking for headlines about obesity. You can find lots of talk about obesity everywhere you turn. The problem is that all […]
August 9, 2015 — Progress in developing obesity care options is very encouraging, and at the same time frustrating. Friday, Novo Nordisk reported on early results from introducing Saxenda — the fourth new obesity treatment in as many years — into the U.S. Uptake is encouraging, with prescriptions that are growing steadily at a volume comparable to other recent introductions. For […]
